共 409 条
[1]
Goldhirsch A(2013)Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 Ann Oncol 24 2206-2223
[2]
Winer EP(2000)Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer N Engl J Med 342 525-533
[3]
Coates AS(2005)A pooled analysis of bone marrow micrometastasis in breast cancer N Engl J Med 353 793-802
[4]
Gelber RD(2010)Disseminated tumor cells in bone marrow assessed by TWIST1, cytokeratin 19, and mammaglobin A mRNA predict clinical outcome in operable breast cancer patients Clin Breast Cancer 10 378-384
[5]
Piccart-Gebhart M(2003)Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer J Clin Oncol 21 3469-3478
[6]
Thurlimann B(2011)Disseminated tumor cells in the bone marrow of patients with ductal carcinoma in situ Int J Cancer 129 2522-2526
[7]
Senn HJ(2010)Effect of zoledronic acid on disseminated tumour cells in women with locally advanced breast cancer: an open label, randomised, phase 2 trial Lancet Oncol 11 421-428
[8]
Braun S(2012)The impact of menopause on bone, zoledronic acid, and implications for breast cancer growth and metastasis Ann Oncol 23 2782-2790
[9]
Pantel K(2010)Effect of zoledronate on persisting isolated tumour cells in patients with early breast cancer Anticancer Res 30 1807-1813
[10]
Muller P(2012)Influence of zoledronic acid on disseminated tumor cells in primary breast cancer patients Ann Oncol 23 2271-2277